BioCentury
ARTICLE | Clinical News

Intelence etravirine regulatory update

September 7, 2009 7:00 AM UTC

J&J's Tibotec Pharmaceuticals Ltd. unit issued a Dear Healthcare Professional letter and updated the label for Intelence etravirine to warn about fatal cases of toxic epidermal necrolysis as well as h...